At present, the EU is strengthening its drug monitoring capacities through stricter pharmacovigilance (PV) process. Market experts predict that it is due to the rising number of adverse drug reactions (ADRs), the ageing population, and the rising chronic disease burden.
In light of the EU’s evolving regulatory environment, pharma organisations are now trying to ramp up their PV activities. Their focus is now shifting from primarily safety operations to proactive risk management, personalised medicine, and facilitating transparency between pharma, patients, healthcare providers and regulatory agencies. To aid in their efforts, they are turning towards cloud-based solutions, mobile applications, robotic automation, artificial intelligence (AI), and big data analytics. By applying innovative technology automation tools and processes to PV strategies, the foresighted organisations are securing their future in the European pharmaceutical space.
In the wake of such trends in the sector, Pharma Tech Outlook has compiled a list of accomplished pharmacovigilance solution providers most suited for the current market requirements. Equipped with innovative technological capabilities, these pharmacovigilance solution providers are set to transform the pharma landscape. This edition also blends thought leadership articles from subject-matter experts, CIOs, and CXOs, with real-life stories on how the solution providers have enhanced the capabilities of their clients. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organisation need, to foster a workspace driven by robust and efficient technology.
We present to you Pharma Tech Outlook’s, “Top 10 Pharmacovigilance Solution Companies in Europe – 2021.”


![Top Pharmacovigilance Solution Companies in Europe Novartis [Swx: Novn] : Helping Create A Healthier And Safer World](https://www.pharmatechoutlook.com/uploaded_images/magazine_img/6zrpzUntitled-3.jpg)











